Use of Continuation or Maintenance Electroconvulsive Therapy in Adolescents With Severe Treatment-Resistant Depression

被引:28
|
作者
Ghaziuddin, Neera [1 ]
Dumas, Sara [1 ]
Hodges, Elise [1 ]
机构
[1] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
关键词
adolescent; treatment-resistant major depression; ECT; SEVERE MOOD DISORDER; FOLLOW-UP; ECT; RELAPSE; PHARMACOTHERAPY; CONSORTIUM; OUTCOMES; CORE; LIFE;
D O I
10.1097/YCT.0b013e3181f665e4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Retrospective data are presented for 6 adolescents ranging in age from 14 to 17 years, who were diagnosed with severe treatment-resistant major depression (TRD). Subjects were treated with one or more index courses of electroconvulsive therapy (ECT) followed by continuation ECT (C-ECT, up to 6 months of ECT) or maintenance ECT (M-ECT; ECT beyond 6 months) when necessary. Electroconvulsive therapy was continued until remission or until minimal residual symptoms were evident. Pharmacotherapy and psychotherapy were reintroduced during C-ECT or M-ECT. Premorbid functioning was achieved by 5 of 6 cases. Cognitive deficits were not evident. In fact, comparison of pre-ECT and post-ECT neuropsychological functioning revealed a trend toward improved auditory and verbal memory on most of the results. We concluded that C-ECT and M-ECT are useful and safe treatment strategies for selected adolescents with severe treatment-resistant depression, and symptom remission may be achieved without experiencing cognitive impairment.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 50 条
  • [1] Pramipexole and Electroconvulsive Therapy in Treatment-Resistant Depression
    Gauthier, Claire
    Souaiby, Lama
    Advenier-Iakovlev, Emmanuelle
    Gaillard, Raphael
    [J]. CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) : 264 - 267
  • [2] Evaluation of the efficacy of the continuation electroconvulsive therapy in treatment-resistant schizophrenia
    Gul, Isil Gogcegoz
    Eryilmaz, Gul
    Sayar, Gokben Hizli
    Ozten, Eylem
    Arat, Mustafa Murat
    Tarhan, Nevzat
    [J]. REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (04): : 90 - 94
  • [3] Electroconvulsive Therapy for Treatment-Resistant Depression Dispelling the Stigma
    Salani, Deborah
    Goldin, Deana
    Valdes, Beatriz
    DeSantis, Joseph
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2023, 61 (06) : 11 - 17
  • [4] Electroconvulsive therapy and cognitive functions in treatment-resistant depression
    Bodnar, Anna
    Krzywotulski, Milosz
    Lewandowska, Anna
    Chlopocka-Wozniak, Maria
    Bartkowska-Sniatkowska, Alicja
    Michalak, Michal
    Rybakowski, Janusz K.
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (02): : 159 - 164
  • [5] Remission of Treatment-Resistant Depression With Electroconvulsive Therapy and Ketamine
    Niemegeers, Peter
    Schrijvers, Didier
    Madani, Yamina
    Sabbe, Bernard G. C.
    [J]. JOURNAL OF ECT, 2014, 30 (03) : E31 - E32
  • [6] Psychiatric polypharmacy and electroconvulsive therapy in treatment-resistant depression
    Zoellner, Rebecca
    Huber, Martin T.
    Mangelsdorf, Constanze
    Konrad, Carsten
    Zavorotnyy, Maxim
    [J]. NERVENARZT, 2020, 91 (07): : 624 - 634
  • [7] Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
    Baldinger-Melich, Pia
    Spies, Marie
    Bozic, Ina
    Kasper, Siegfried
    Rujescu, Dan
    Frey, Richard
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [8] Use of Electroconvulsive Therapy in Adolescents With Treatment-Resistant Depressive Disorders A Case Series
    Zhand, Naista
    Courtney, Darren B.
    Flament, Martine F.
    [J]. JOURNAL OF ECT, 2015, 31 (04) : 238 - 245
  • [9] Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression
    Burke, Michael J.
    Husain, Mustafa M.
    [J]. JOURNAL OF ECT, 2006, 22 (03) : 218 - 222
  • [10] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384